For instance, PPC nanoparticles enhance tumor immunogenicity by degrading HER2 and inducing ICD through PDT, while PFB nanozymes remodel the microenvironment via catalytic activity and metabolic starvation. The gene discussed is ERBB2; the disease is neoplasm.